Podcast: Mosquito Saliva Vaccine Evaluated in Phase 1 Clinical Trial

Malaria Minute, 19 June 2020

Researchers evaluate the immunogenicity of the AGS-v vaccine which targets saliva produced by Anopheles gambiae mosquitoes.

Listen to this Podcast